Literature DB >> 15769800

The physician workforce crisis: where is the evidence?

David C Goodman1.   

Abstract

Barbara Starfield and colleagues present evidence that having more primary care physicians and fewer specialists per capita is associated with lower mortality rates. These analyses stand in contrast to those guiding national workforce policy recommendations, which use current physician-to-population ratios as a normative reference for future physician requirements. Proponents of physician training expansion need to establish a body of evidence that having additional physicians will lead to improved health and well-being of patients and populations. Research to date, in contrast, indicates that physician workforce levels, particularly of specialists, are not a primary factor in determining health outcomes.

Entities:  

Mesh:

Year:  2005        PMID: 15769800     DOI: 10.1377/hlthaff.w5.108

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  4 in total

1.  Expanding the US medical workforce: global perspectives and parallels.

Authors:  Jonathan P Weiner
Journal:  BMJ       Date:  2007-08-04

Review 2.  Challenges and strategies for determining workforce requirements in plastic surgery.

Authors:  Kevin Cheung; Arthur Sweetman; Achilleas Thoma
Journal:  Can J Plast Surg       Date:  2012

3.  An International Health Track Is Associated With Care for Underserved US Populations in Subsequent Clinical Practice.

Authors:  Andrew W Bazemore; Linda M Goldenhar; Christopher J Lindsell; Philip M Diller; Mark K Huntington
Journal:  J Grad Med Educ       Date:  2011-06

4.  Palliative chemotherapy among people living in poverty with metastasised colon cancer: facilitation by primary care and health insurance.

Authors:  Kevin M Gorey; Emma Bartfay; Sindu M Kanjeekal; Frances C Wright; Caroline Hamm; Isaac N Luginaah; Guangyong Zou; Eric J Holowaty; Nancy L Richter; Madhan K Balagurusamy
Journal:  BMJ Support Palliat Care       Date:  2016-08-23       Impact factor: 4.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.